Stock Incentive Plans

9 Months Ended

Sep. 30, 2022

Share-Based Payment Arrangement [Abstract]

Stock Incentive Plans

NOTE 8 - Stock Incentive Plans

Stock Options

The following table summarizes stock option activity for the nine-month period ended September 30, 2022:

	Options Outstanding
	Shares			Weighted Average Exercise Price
Outstanding, December 31, 2021		19,203		$	19.40
Options expired / forfeited		(203	)		34.00
Outstanding, September 30, 2022		19,000			19.60
Exercisable, September 30, 2022		19,000		$	19.60

No stock options were granted during the nine-month period ended September 30, 2022.

The following table summarizes additional information on the Company’s stock options outstanding at September 30, 2022:

	Options Outstanding						Options Exercisable
Exercise Price	Number Outstanding		Weighted- Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price
19.60		19,000		0.59	$	19.60		19,000	$	19.60
Totals		19,000		0.59	$	19.60		19,000	$	19.60

ADHERA THERAPEUTICS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

For the Three and Nine Months Ended September 30, 2022

(Unaudited)

As of September 30, 2022, the Company had no unrecognized compensation expense related to unvested stock options. No stock based compensation expenses was recognized for the three or nine-month periods ended September 30, 2022 or 2021.

As of September 30, 2022, the intrinsic value of options outstanding or exercisable was zero there were no options outstanding with an exercise price less than the closing market price of our common stock at that date.